Stephan Dickgiesser

Principal Scientist
Merck KGaA
Stephan Dickgiesser
Stephan Dickgiesser is a principal scientist at the department of ADCs & Targeted NBE Therapeutics at Merck KGaA in Darmstadt, Germany. He is responsible for development and evaluation of new technologies for ADC generation and an expert in ADC bioconjugation and analytics. Stephan has studied molecular biotechnology (M.Sc.) at the Technical University of Munich and received his PhD in protein engineering and biochemistry with Prof. Harald Kolmar at the Technical University of Darmstadt. He has been working on ADCs since he joined Merck as a PostDoc in 2015.”


No data was found